Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Super Micro Computer Inc (SMCI) vs 10X Genomics Inc (TXG) Price & Performance

Super Micro Computer IncTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Super Micro Computer Inc vs 10X Genomics Inc — how do they compare? Super Micro Computer Inc trades at $38.5 (market cap $25.58B), while 10X Genomics Inc trades at $67.59 (market cap $8.77B). The key difference: Super Micro Computer Inc is far larger — about 2.9× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Super Micro Computer Inc nearer its low. Which is the better fit depends on your goals.

SMCITXG
Market Cap
$25.58B$8.77B
Sector
TechnologyHealth
52-Week High
$58.68$67.29
52-Week Low
$20.53$11.34
Enterprise Value
$31.04B$8.29B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Super Micro Computer Inc

Super Micro Computer (SMCI) trades at $40.26, up 1.69% with a bullish technical signal and strong AI-driven growth. The stock shows robust fundamentals with revenue reaching $21.97B in 2025 and net income of $1.05B, while consistently beating earnings estimates. Recent news highlights strong AI infrastructure demand and margin improvements, though some caution exists around sustainability.

SMCI presents a compelling growth story fueled by AI server demand, with attractive valuations (P/E 11.94, P/S 0.69) and analyst consensus price target of $40.57. Key risks include margin sustainability concerns and cash flow volatility, but the company's market position and earnings momentum support continued upside potential for investors.

10X Genomics Inc

TXG trades at $65.60, up 4.71% today, with a bullish technical signal and recent earnings beats. The stock shows improving fundamentals, with 2025 revenue at $642.82M and net loss narrowing to -$43.54M. Positive sentiment is driven by patent wins, Atera platform demand, and institutional interest, though valuation metrics like P/S of 13.58 and EV/EBITDA of 142.2 remain elevated.

Outlook is cautiously optimistic with upside potential from Atera execution, but risks include high valuation, persistent losses, and competitive pressures. Analyst consensus is mixed with a $50.56 price target below current levels, indicating near-term caution despite long-term growth prospects in genomics.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Super Micro Computer Inc

Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.

Read more on SMCI

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG